Furthermore, it would be intriguing to explore in a larger cohort the value of CXCL13 as a biomarker for specific complications in CVID, along with other suggested biomarkers such as IL-10 or CXCL10 [54, 73]. This evidence concerns the gene IL10 and common variable immunodeficiency.